e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
Smoking related disorders and smoking cessation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD
M. Hoogendoorn, T. Feenstra, R. Hoogenveen, M. Rutten-van Mölken (Rotterdam, Bilthoven, Groningen, Netherlands)
Source:
Annual Congress 2010 - Smoking related disorders and smoking cessation
Session:
Smoking related disorders and smoking cessation
Session type:
Oral Presentation
Number:
5145
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Hoogendoorn, T. Feenstra, R. Hoogenveen, M. Rutten-van Mölken (Rotterdam, Bilthoven, Groningen, Netherlands). Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD. Eur Respir J 2010; 36: Suppl. 54, 5145
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Effectiveness and cost-effectiveness of smoking cessation interventions
Source: International Congress 2015 – New advances in smoking cessation interventions
Year: 2015
The cost-effectiveness of antidepressants for smoking cessation in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 801s
Year: 2006
Smoking cessation in COPD, modelling the cost effectiveness of minimal counseling or intensive counseling plus bupropion
Source: Eur Respir J 2004; 24: Suppl. 48, 463s
Year: 2004
Cost-effectiveness of 5 smoking cessation interventions
Source: Eur Respir J 2004; 24: Suppl. 48, 463s
Year: 2004
Effectiveness of a specialised intervention for smoking cessation in hospitalised patients
Source: Annual Congress 2007 - Smoking cessation
Year: 2007
Comparison of effectiveness of varenicline and NRTs in smoking cessation in patients with chronic diseases
Source: Annual Congress 2008 - Smoking cessation and new tobacco uses
Year: 2008
Smoking cessation compared to treatment of COPD and other smoking-related diseases using cost-effectiveness evidence
Source: Annual Congress 2009 - Sustainability in treatment of COPD patients according to economics and quality of care
Year: 2009
Evidence of the effectiveness and safety of first-line smoking cessation pharmacotherapy
Source: Eur Respir Monogr 2021; 90: 97-117
Year: 2021
Comparison of efficacy of varenicline and nortriptyline– Short-term smoking cessation in outpatient setting
Source: International Congress 2016 – Emerging issues in smoking cessation and tobacco products
Year: 2016
Different types of medical intervention and the smoking cessation rate in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 107s
Year: 2006
Effectiveness of varenicline as an aid to smoking cessation in primary care: An observational study
Source: Annual Congress 2012 - Tobacco cessation
Year: 2012
Efficacy and safety of bupropion for the treatment of smoking cessation in patients with chronic bronchitis
Source: Eur Respir J 2004; 24: Suppl. 48, 503s
Year: 2004
Cost effectiveness of retreatment with varenicline compared to other commonly used smoking cessation interventions
Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards
Year: 2015
Smoking cessation strategies in patients with COPD
Source: Eur Respir J 2013; 41: 727-734
Year: 2013
Effectiveness of smoking cessation in patients with psychiatric disease
Source: Annual Congress 2012 - Tobacco comorbidity
Year: 2012
Effectiveness of varenicline treatment in a smoking cessation clinic
Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation
Year: 2009
Cost-effectiveness of a lung health intervention in US smokers
Source: Annual Congress 2011 - Smoking-related diseases and smoking cessation
Year: 2011
Efficacy of instant messages applications in smoking cessation in patients with COPD.
Source: Virtual Congress 2021 – Digital health interventions in respiratory medicine
Year: 2021
Long-term effectiveness of PEF-guided self-management in asthma
Source: Annual Congress 2007 - Novel issues in the treatment and control of asthma
Year: 2007
The costs of smoking and the economics of smoking cessation
Source: Eur Respir Mon; 2008: 42: 23–34
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept